- Abstract:
-
Injections with a hypodermic needle and syringe (HNS) are the current standard of care globally, but the use of needles is not without limitation. While a plethora of needle-free injection devices exist, vaccine reformulation is costly and presents a barrier to their widespread clinical application. To provide a simple, needle-free, and broad-spectrum protein antigen delivery platform, we developed novel potassium-doped hydroxyapatite (K-Hap) microparticles with improved protein loading capab...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted Manuscript
- Files:
-
-
(vnd.openxmlformats-officedocument, 890.7kb)
-
- Publisher copy:
- 10.1128/cvi.00121-15
- Publisher:
- American Society for Microbiology Publisher's website
- Journal:
- Clinical and vaccine immunology : CVI Journal website
- Volume:
- 22
- Issue:
- 5
- Pages:
- 586-592
- Publication date:
- 2015
- DOI:
- EISSN:
-
1556-679X
- ISSN:
-
1556-6811
- URN:
-
uuid:ee7aa39e-7457-4217-ae1d-7d1ee7a6971e
- Source identifiers:
-
517025
- Local pid:
- pubs:517025
- Language:
- English
- Copyright holder:
- American Society for Microbiology
- Copyright date:
- 2015
- Notes:
- Copyright © 2015, American Society for Microbiology.
Journal article
Needle-free dermal delivery of a diphtheria toxin CRM197 mutant on potassium-doped hydroxyapatite microparticles
Actions
Access Document
Authors
Funding
Oxford Martin School
More from this funder
University of Oxford
More from this funder
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record